Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-05

FDA Approved: LEVETIRACETAM — Supplemental Application (Hisun Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM from Hisun Pharmaceuticals USA, Inc., resulting in approval of a generic version of the epilepsy medic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)